OTCMKTS:CONX - Corgenix Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous Close$0.2640
Today's RangeN/A
52-Week Range$0.20 - $0.56
Average Volume387,641 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Corgenix Medical Corporation is engaged in research, development, manufacture, and marketing of in vitro diagnostic (IVD) products (tested outside the human body) for use in disease detection and diagnosis. The Company's products are used in clinical laboratories for the diagnosis and/or the monitoring of three important sectors of health care: Autoimmune disease, Vascular disease and Liver diseases. The Company develops and manufactures products in several commonly utilized testing formats, such as Microplate Enzyme Linked ImmunoSorbent Assay (ELISA), Lateral Flow Immunoassay (LFI) and Immmunoturbidimetry (IT). The Company sells ELISA tests in markets across the world. The Company's product line, commercialized under the trademarks REAADS and Corgenix.

Receive CONX News and Ratings via Email

Sign-up to receive the latest news and ratings for CONX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Current SymbolOTCMKTS:CONX



Sales & Book Value

Annual SalesN/A



OptionableNot Optionable

Corgenix Medical (OTCMKTS:CONX) Frequently Asked Questions

What is Corgenix Medical's stock symbol?

Corgenix Medical trades on the OTCMKTS under the ticker symbol "CONX."

Has Corgenix Medical been receiving favorable news coverage?

News stories about CONX stock have been trending somewhat positive recently, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Corgenix Medical earned a news impact score of 1.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Corgenix Medical?

Shares of CONX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Corgenix Medical's official website?

The official website for Corgenix Medical is http://www.corgenix.com.

How can I contact Corgenix Medical?

Corgenix Medical's mailing address is 11575 Main St Unit 400, BROOMFIELD, CO 80020-2782, United States. The company can be reached via phone at +1-303-4574345.

MarketBeat Community Rating for Corgenix Medical (OTCMKTS CONX)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  23 (Vote Underperform)
Total Votes:  61
MarketBeat's community ratings are surveys of what our community members think about Corgenix Medical and other stocks. Vote "Outperform" if you believe CONX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CONX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel